Hi everyone.
On 15/02/2023, our system had provided a few picks and the results are as below:
CRWD – (Buy) – Loss
DHR – (Sell) – Profit
BMRN – (Sell) – Withdrawn
SNOW – (Buy) – Withdrawn
The Dow Jones finished roughly 40 points higher on Wednesday, while the S&P 500 and the Nasdaq added 0.2% and 0.9%, respectively, as investors weighed January retail sales and inflation data while remained cautious about prolonged rate hikes.
Let’s review our stock picks on Wednesday.
A call for buy for CRWD which resulted in a loss. Our system entered the market at $116.27 and the price hit our stop loss at $115.70, before moving upwards again and hitting our TP.
CrowdStrike Holdings, Inc. provides cloud-delivered protection across endpoints and cloud workloads, identity, and data. It offers threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management.
A call for buy for CRWD which resulted in a profit. Our system entered the market at $256.18 and made a call to profit at $254.26, which is our trailing stop loss.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy.
A call for sell for BMRN which was withdrawn. Our system withdrew because the price did not hit our EP within a set amount of time.
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form of 6R-BH4 that is used to treat patients with phenylketonuria (PKU), an inherited metabolic disease.
A call for buy for SNOW which was withdrawn. Our system withdrew because the price did not hit our EP within a set amount of time.
Snowflake Inc. provides a cloud-based data platform in the United States and internationally. The company’s platform offers Data Cloud, which enables customers to consolidate data into a single source of truth to drive meaningful business insights, build data-driven applications, and share data. Its platform is used by various organizations of sizes in a range of industries.
Stay tuned for more of our stock picks.
Want the next pick before it's written up?
AIRESCAN's AI publishes live recommendations in the app.